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Abstract
Background: Obesity is a chronic disease associated to an inflammatory process resulting in oxidative stress that
leads to morpho-functional microvascular damage that could be improved by some dietary interventions. In this
study, the intake of Brazil nuts (Bertholletia excelsa), composed of bioactive substances like selenium, a-eg-
tocopherol, folate and polyunsaturated fatty acids, have been investigated on antioxidant capacity, lipid and
metabolic profiles and nutritive skin microcirculation in obese adolescents.
Methods: Obese female adolescents (n = 17), 15.4 ± 2.0 years and BMI of 35.6 ± 3.3 kg/m
2, were randomized 1:1
in two groups with the diet supplemented either with Brazil nuts [BNG, n = 08, 15-25 g/day (equivalent to 3 to 5
units/day)] or placebo [PG (lactose), n = 09, one capsule/day] and followed for 16 weeks. Anthropometry,
metabolic-lipid profiles, oxidative stress and morphological (capillary diameters) and functional [functional capillary
density, red blood cell velocity (RBCV) at baseline and peak (RBCVmax) and time (TRBCVmax) to reach it during
post-occlusive reactive hyperemia, after 1 min arterial occlusion] microvascular variables were assessed by nailfold
videocapillaroscopy at baseline (T0) and after intervention (T1).
Results: T0 characteristics were similar between groups. At T1, BNG (intra-group variation) had increased selenium
levels (p = 0.02), RBCV (p = 0.03) and RBCVmax (p = 0.03) and reduced total (TC) (p = 0.02) and LDL-cholesterol
(p = 0.02). Compared to PG, Brazil nuts intake reduced TC (p = 0.003), triglycerides (p = 0.05) and LDL-ox (p = 0.02)
and increased RBCV (p = 0.03).
Conclusion: Brazil nuts intake improved the lipid profile and microvascular function in obese adolescents, possibly
due to its high level of unsaturated fatty acids and bioactive substances.
Trial Registration: Clinical Trials.gov NCT00937599
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Background
Worldwide prevalence of obesity in adolescence is actu-
ally high and increasing [1]. In Brazil, about 29% of ado-
lescents tested between 2008-2009 have excessive weight
[2]. Obesity, especially abdominal, even in young sub-
jects leads to metabolic alterations, such as insulin
resistance and dyslipidaemia, increasing risk factors for
cardiovascular disease (CVD) in adulthood [3].
Excessive abdominal adiposity is characterized by accu-
mulation of adipose tissue and is associated to a low-
grade inflammatory process and oxidative stress, both
well-established pathogenetic factors for cardiovascular
diseases [4]. Morpho-functional microvascular alterations
related to metabolic disorders have already been
described and findings on skin were related to microvas-
cular dysfunction on coronary bed [5], occurring even in
the absence of disglycaemic states [6] pointing to obesity
per se as independent risk factor for microangiopathy.
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involved on it as well. Recently, we have unraveled that
overweight/obese young women have microvascular
dysfunction linked to adiposity levels and glucose home-
ostasis [7]. Certainly, obesity in adolescence and its
long-term damage to target organs in adulthood deserves
special focus and strategies to reduce future cardiovascu-
lar risks.
Excessive visceral fat induces the release of cytokines,
such as tumor necrosis factor-alfa (TNFa)a n di n t e r l e u -
kin-6 (IL-6) leading to increased production of reactive
oxygen species (ROS) and subsequent induction of tis-
sue oxidative stress [8]. Some authors consider this
pathophysiological process as a major mechanism
underlying cardiovascular obesity-related comorbidities
[9]. The antioxidant system is directly linked to environ-
mental factors and nutrient intake. Some minerals such
as selenium are also involved in decreasing levels of
hydrogen peroxide and reducing lesions to cellular mem-
branes [10]. Altered metabolic pathway of very low
density lipoprotein cholesterol (VLDL) secondary to
excessive visceral adiposity results on higher levels of low
density lipoprotein (LDL) particles, which are more
aggressive to endothelium. Additionally, the oxidative
stress increases oxidation of these LDL particles [11], a
process identified as a risk factor for atherosclerosis [12].
Bioactive substances existing in nuts have already been
identified [13] and their beneficial effects on inflamma-
tion [14] and on endothelial function [15] demonstrated.
The Brazil nut (Bertholletia excelsa) comes from the
Amazon region and has a complex matrix, composed of
bioactive substances, such as selenium, a-eg- toco-
pherol, phenolic compounds, folate, magnesium, potas-
sium, calcium, proteins and mono (MUFA) and
polyunsaturated (PUFA) fatty acids [14]. Its composition
is different from other nuts and data to corroborate its
beneficial effects, especially in obese adolescents with
special focus on microcirculatory function are lacking.
The aims of this study were to investigate the influ-
ence of Brazil nuts consumption on nutritive skin
microcirculation, serum antioxidant capacity, lipid and
metabolic/cardiovascular risk profiles in obese female
adolescents.
Subjects and Methods
Study Population
Seventeen female adolescents (15.4 ± 2.0 years) were
selected, after spontaneous interest to participate (male
adolescents showed very little interest), from outpatient
care clinics for Prevention and Assistance on Cardiovas-
cular and Metabolic Disease in Adolescence (NESA,
State University of Rio de Janeiro, Brazil). Main inclu-
sion criterion was being above 95
th percentile for BMI
according to age [16]. Main exclusion criteria were: use
of any nutritional intervention and/or drugs; presence of
chronic diseases (diabetes mellitus and/or hypertension)
or lactose intolerance; a verbally informed weight reduc-
tion six months before entering the study; being beyond
stage IV for Tanner pubertal development [17] and diet-
ary habits of an excessive consumption of any kind of
nut. All volunteers gave their written informed consent
and this study was approved by the Ethics Committee
for Clinical Research of Pedro Ernesto University Hospi-
tal (COEP 1950/2007).
Experimental Design
The study was a 16-week non-blinded pilot trial with
two randomly selected groups of obese female adoles-
cents: Brazil nut (BNG, n = 08) ingested 15-25 g/day
(equivalent to 3 to 5 units/day) of Brazil nuts and pla-
cebo (PG, n = 09) one capsule/day containing lactose.
Lactose was chosen as placebo due to its lack of thera-
peutic effects to improve adolescents’ compliance to the
study. Both groups were informed that they would
receive a supplemental dietary intake composed of Brazil
nuts but only one group would receive it on its natural
f o r m .N u t sw e r ec o n s u m e da ss n a c k so rw i t hm e a l si n
salads. Before the beginning and at the end of the study,
the usual food intake of each participant was assessed
by a dietary inquiry and, during the study, adolescents
were advised not to change their dietary habits.
Anthropometry, blood, urine and microvascular para-
meters were analyzed at baseline (T0) and after 16
weeks (T1).
Brazil Nuts Diet
Brazil nuts (Bertholletia excelsa)c o n s u m p t i o nw a s
calculated to achieve 10% of the energy from MUFAs in
the diet. Total energy intake was calculated by energy
expenditure to overweight children and adolescents of 3 to
18 years according to dietary reference intake (DRI). Ado-
lescents received 15-25 g/day (equivalent to 3 to 5 units/
day) in bags. Serum selenium levels and returned empty
bags were used as markers of compliance for BNG.
Brazil nut composition was determined in 100 g by
Adolph Lutz Institute-Brazil assays (1985). Lipid, carbo-
hydrates and protein content (mean ± SD) was 50.6 ±
0.08 g [coefficient of variation (CV) 1.6%], 25.9 ± 0.6 g
(CV 2.4%) and 16.8 ± 0.2 g (CV 1.4%). Selenium was
measured by flame atomic absorption spectrometry.
Saturated (SFA - 15.3 g), monounsaturated (MUFA -
27.4 g) and polyunsaturated (PUFA) fatty acids (21 g) con-
tents were calculated according to Brazilian Table of Food
Composition [18]. Therefore, nut intake (15-25 g/day)
was about: 124 ± 31 kcal with 5.2 ± 1.3 g of carbohydrates
and 10.1 ± 2.5 g of lipids. The latter was composed of
4.2 ± 1.0 g of PUFA, 5.5 ± 1.4 g of MUFA and 3.0 ± 0.7 g
of SFA and 108.5 ± 27 μg of selenium.
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The same trained examiner collected anthropometric
measurements in duplicate, waist circumference, height,
weight as previously reported [19]. BMI was defined as
the ratio between weight in kg and squared height in
meters.
Laboratory Analysis
All laboratory measurements were performed in dupli-
cate after 10-12 hours fast using an automated method
(Modular Analytics E 170 and P, Roche, Basel, Switzer-
land). Fasting plasma glucose (FPG), total cholesterol
(TC), triglycerides (TG) and high-density lipoprotein
(HDL) cholesterol were measured respectively, by
enzyme-colorimetric GOD-PAP [inter-assay coefficient
of variation (IACV) = 1.09%], enzymatic GPO-PAP
(IACV = 2.93%), enzymatic GPO-PAP (IACV = 1.29%)
and enzyme-colorimetric without pre-treatment (IACV
= 3.23%). Plasma LDL-cholesterol was calculated
according to Friedwald equation [20]. C-reactive protein
and serum insulin were respectively measured by imu-
noturbidimetry (IACV = 8%) and eletrochemiluminescence
(IACV = 10.6%). Homeostasis model assessment (HOMA-
IR) was calculated (fasting serum insulin (μUI/ml) X FPG
(mmol/l)/22.5). Serum antioxidant capacity was deter-
mined by glutathione peroxidase (GPx) through Elisa
[GPX3 (human) Elisa Kit, Axxora, LLC, USA, diluted in
1:200 (IACV = 3.9%; sensitivity = 0.1 ng/ml]. Oxidized-
LDL (ox-LDL) levels were also analyzed through Elisa
(Kit Mercodia, Sweden), diluted in 1:6561 (IACV = 6.13%;
sensitivity = 0.05 ng/ml). Oxidative stress was measured by
a competitive enzyme-linked immunosorbant assay in
duplicate determining levels of isoprostane nominated as
8-epi-prostaglandin F2a (8-epi-PGF2a)i nu r i n es a m p l e s
(BIOXYTECH urinary 8-epi-PGF2a - OxisResearch, Port-
land, OR, USA). Urinary samples were acidified during
collection with HCl 6 mol/l (final pH = 2.0), diluted to 1:2
before measurements and results were corrected for creati-
nine levels in each sample assessed by enzymatic colori-
metric Modular Evo (Roche) with an intra-assay CV of 5%
( 2 - 1 4 % )[ 1 9 ]S e r u ms e l e n i u mw a sd e t e r m i n e dt h r o u g h
atomic absorption spectrometry using a SpectraAA - 640Z
-V A R I A N( I A C V=1 1 % ) .
Microvascular Function Assessment
Nailfold videocapillaroscopy (NVC) was carried out and
analyzed according to a standardized, well-validated
methodology on the 4
th finger of the left hand [7]. The
exam, always made by the same observer who was not
aware of any patient data, recorded continuously micro-
vascular parameters for later measurements using the
Cap Image software [21]. Functional capillary density
(FCD), number of capillaries/mm
2 with flowing red
blood cells, was evaluated using x250 magnification and
an area of 3 mm of the distal row of capillaries into
three different areas [Intra-assay coefficient of variation
- IACV = 5.5 ± 2.5%]. Capillary diameters [afferent
(AF), apical (AP) and efferent (EF)], red blood cell velo-
city (RBCV) at rest, after 1 min arterial occlusion
(RBCVmax) and time taken to reach it (TRBCVmax)w e r e
measured, with a final magnification of x680, before and
during the post-occlusive reactive hyperemia (PORH)
response after 1 min ischemia. Before RBCV assessment
on an individual capillary loop, a pressure cuff (1 cm
wide) was placed around the proximal phalanx and con-
nected to a mercury manometer. Conceptually, AF, AP
and EF are considered morphological and FCD, RBCV,
RBCVmax and TRBCVmax functional microcirculatory
parameters. Capillary diameters and basal RBCV were
measured three times each and IACV for all measure-
ments ranged from 16.9 to 17.1%. At PORH, each
variable was tested once. NVC was repeated on nine
subjects in different days and the IACV ranged from
12.3% to 17.3% and from 2.0% to 9.0% between morpho-
logical and functional parameters, respectively.
Statisticals Analysis
Data are expressed as median [1
st-3
rd] and analyzed by
Graphpad Prism 4.0, 2003 and intra- or inter-group analy-
s i sc o m p a r e ss i g n i f i c a n tr e s u lts in different time points
within the same group or between BNG and PG, respec-
tively. Comparisons between groups at T0 and T1
and intra-group differences were determined using
Mann-Whitney U test and Wilcoxon matched pair
tests, respectively. GPower 3.1.10 software was used
for power analysis and sample size estimation. The sta-
tistical power for comparisons between two dependent
groups was above 0.9 with an a error probability of
0.01 for RBCV, estimating a total sample size of 7
patients/group. Significant differences were assumed to
be present at p <0 . 0 5 .
Results
Adolescents included in the study had 15.4 ± 2.0 years
and BMI of 35.6 ± 3.3 kg/m
2. At T0, there were no sig-
nificant differences between groups (inter-group) on
anthropometrical-laboratorial-microvascular variables
(tables 1, 2 and 3). On the counterpart, at T1, we
observed lower values for total (p = 0.003) and LDL-
cholesterol (p = 0.03), and also for TG (p =0 . 0 5 )f o r
BNG compared to PG.
Body mass, BMI, waist circumference and metabolic
profile were all kept unchanged during the follow-up on
both groups. Additionally, we have noticed that Brazil
nuts consumption did not influence glucose homeostasis
(FPG, insulin, HOMA-IR) or CRP levels, although its
positive influence was observed on LDL- (p = 0.01) and
total cholesterol (p = 0.01) levels (table 1).
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between groups. Gpx, LDL-ox and 8-epi-PGF2a did not
change during the follow-up in either group (Table 2).
I ts h o u l db eh i g h l i g h t e dt h a ta tT 1 ,s e r u ml e v e l so f
LDL-ox were lower on BNG when compared to PG (p =
0.02), while on PG, serum selenium levels, a marker of
compliance for the proposed intervention, was kept
unchanged [118 (107.5-148.5 μg/l) vs. 126 (106.5-146.5
μg/l), p = 0.74] but on BNG we have observed a signifi-
cant increase [110.5 (87.5-131.5 μg/l) vs. 133 (104.5-178
μg/l), p = 0.02] (Figure 1).
Morphological microvascular parameters (capillary
diameters - Table 3) did not change during the fol-
low-up in both groups. Obese female adolescent in
PG had all functional microvascular parameters unal-
tered during the follow-up but those supplemented
with Brazil nuts (BNG) increased RBCV and RBCVmax
during PORH 13.9% and 9.52%, respectively (intra-
g r o u pr e s u l t s )( F i g u r e2 ) .A d d i t i o n a l l y ,R B C Va tT 1
was higher on BNG when compared to PG at the
same time point [1.63(1.6-1.7) vs. 1.54 (1.4-1.56) mm/s;
p = 0.02].
Discussion
Obesity is associated to metabolic disturbances, includ-
ing insulin resistance, dyslipidemia and low-grade
inflammation, all of them putative factors for endothelial
and microvascular dysfunction (MD). Frequent nut
intake is associated with many health benefits in adults
[22-24], although no studies on adolescents could be
found. To the best of our knowledge, this study is the
first one to investigate effects of Brazil nuts intake on
metabolic-lipid profiles, antioxidant status and microvas-
cular parameters in obese female of this specific age
period.
Nuts are rich in lipids, mainly in MUFAs and PUFAs
and have high energy density. Comparing fat composi-
tion of diets rich on SFAs, high content of MUFAs and
PUFAs in foodstuffs is potentially beneficial to health
[25]. In spite of the caloric composition, some authors
have demonstrated that consumption of nuts for short
periods (less than 4 weeks) did not increase body mass
[26]. In the present study, both groups kept body mass,
waist circumference and BMI unchanged suggesting that
although Brazil nuts have high energy density, possibly
Table 1 Anthropometric measurements and metabolic profile of obese female adolescents at baseline and after 16
weeks of Brazil nuts (BNG) or placebo (PG) intake
BNG PG
T0 T1 T0 T1
Body mass (kg) 86.3 [82.2-94.3] 86.3[80.3-96.9] 91.7 [82.1-110.8] 93.2[83.7-108.7]
Height (m) 1.55[1.52-1.66] 1.55[1.53-1.67] 1.64[1.56-1.69] 1.64[1.56-1.69]
BMI (kg/m
2) 35.3[33.9-36.0] 35.3[33.3-36.2] 34.0[33.0-39.1] 35.6[32.8-38.9]
Waist circumference (cm) 105.0[93.0-117.8] 112.0[99.5-116.0] 111.0[104.0-117.8] 115.0[107.5-120.0]
Insulin (mcU/ml) 15.9[14.5-23.6] 15.5[12.2-22.2] 18.0[15.2-20.1] 18.0[10.9-22.8]
Fasting glucose (mg/dl) 89.5[81.5-94.0] 86.0 [82.5-93.0] 87.0[82.0-90.5] 90.0[82.0-94.0]
HOMA 3.6[2.9-5.2] 3.5[2.6-6.5] 3.9[3.1-4.4] 3.7[2.2-5.2]
CRP (mg/dl) 0.31[0.15-0.63] 0.37[0.20-0.68] 0.38[0.14-0.78] 0.52[0.29-0.79]
Cholesterol (mg/dl) 152.0[140.5-159.0] 136.0[129.5-141.5] *† 167.0[133.5-184.5] 170.0[148.5-177.0]
HDL-c (mg/dl) 44.0[41.5-48.5] 43.5[40.0-50.5] 45.0[36.0-48.0] 45.0[41.0-47.5]
LDL-c (mg/dl) 86.5[80.5-98.0] 72.5[71.0-83.0] *† 106.0[77.0-123.0] 103.0[87.0-109.0]
TG (mg/dl) 84.5[68.0-98.5] 69.0[58.5-83.5]† 113.5[87.0-132.5] 106.0[77.0-153.0]
* significant results intra-group (p < 0.05).
† significant results inter-group (p < 0.05).
Table 2 Biomarkers with antioxidant capacity in obese female adolescents at baseline and after 16 weeks of Brazil
nuts (BNG) or placebo (PG) intake
BNG PG
T0 T1 T0 T1
8-epi-PGF2a (pg/μmol/g of creatinine) 143.2[102.9-198.8] 100.0[80.0-131.4] 34.0 [61.5-126.6] 88.4[65.0-149.5]
LDL-ox (ng/ml) 622.4[457.2-665.0] 514.9[440.3-624.6]† 648.8[515.9-737.9] 646.9[595.7-883.5]
GPX-3 (ng/ml) 15.5[12.4-19.8] 16.7[12.8-17.3] 17.2[13.7-19.7] 17.3[13.9-20.1]
Selenium (μg/L) 110.5[87.5-131.5] 133.0[104.5-178.0] * 118.0[107.5-148.5] 126.0[106.5-146.5]
* Signicant intra-group results (p < 0.05).
† Signficant inter-group results (p < 0.05).
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chain-triglycerides [27], fiber and protein [26] reduced
energy intake from other sources. Positive influences on
lipid profile by other types of nuts have been already
demonstrated [28]. It has been reported that consump-
tion of Brazil nuts during 15 days did not improve LDL-
and total cholesterol and its benefits were noticed on
transfer of cholesterol into HDL pool. In our study, sup-
plementation of Brazil nuts during 16 weeks to obese
female adolescents positively influenced the lipid profile
such as, total cholesterol (TC), LDL-C and TG, but the
present study did not assess cholesteryl esters.
MD has already been described in obesity [29], meta-
bolic syndrome at normoglycemia [19] and type 2
diabetes mellitus using NVC. This technique is a non-
invasive method to assess microvascular morphology
and function and data obtained using this diagnostic
tool has been already associated to cardiovascular risk
[30]. In our investigation, adolescents were seen every 4
weeks what is roughly during the same phase of the
menstrual cycle and no especial precaution were taken
in this direction because it has already been shown that
microvascular function is not dependent on menstrual
c y c l ei no v u l a t o r yw o m e n[ 3 1 ] .E v e nt e s t e df o rs h o r t -
term period in obese female adolescents, we could
observe an improvement of microvascular reactivity by
supplementing their diet with Brazil nuts and to our
knowledge this is the first clinical study that showed its
Table 3 Microcirculatory parameters on obese female adolescents at baseline and after 16 weeks of Brazil nuts (BNG)
or placebo (PG) intake
BNG PG
T0 T1 T0 T1
Functional capillary density (n/mm
2) 10.2[7.8-11.2] 8.8[8.2-11.8] 9.9[8.0-17.4] 10.2[8.4-13.4]
Afferent diameter (μm) 15.7[13.9-18.6] 15.2[11.8-19.5] 15.1[12.9-18.6] 14.0[11.6-16.1]
Apical diameter (μm) 19.7[18.1-22.3] 22.1[18.2-24.1] 21.9[18.5-27.5] 20.0[18.4-25.6]
Efferent diameter (μm) 20.4[17.5-22.9] 21.6[19.2-25.3] 18.4[15.9-21.5] 21.5[17.8-21.8]
RBCV (mm/s) 1.43[1.38-1.48] 1.63[1.6-1.7] *† 1.47[1.41-1.52] 1.54[1.40-1.56]
RBCVmax (mm/s) 1.68[1.64-1.73] 1.84[1.81-1.94] * 1.71[1.56-1.79] 1.79[1.76-1.84]
TRBCVmax (s) 7.5[6.0-8.0] 4.0[4.0-7.0] 7.5[5.5-8.5] 5.5[5.0-7.0]
* Significant results intra-group (p < 0.05).
† Significant results inter-group (P < 0.05).
Figure 1 Differences in serum selenium levels observed on female obese adolescents during follow-up in both groups. *p = 0.02 (intra-
group) BNG = Brazil Nuts Group; PG = Placebo Group.
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tion, although the effects of PUFAs and MUFAs con-
tained in nuts have been well established on macro and
microvascular functions [15].
Capillary morphology was not influenced by Brazil
nuts consumption. The analysis of the hemodynamic
behavior of the microcirculation was pursued by mea-
suring RBCV before and after 1 min arterial occlusion
as well as the time taken to reach RBCVmax.W eh a v e
chosen 1 min arterial occlusion because our purpose
was to measure the effect of an increased shear stress
during the reactive hyperemia response and to decrease
the discomfort for our patients (1 min ischemia is more
tolerable than 4-6 min) [32]. Longer duration of the
occlusion is commonly used to evaluate capillary
recruitment [33]. In the BNG, a significant improvement
on RBCV at baseline and during PORH could be
detected in conjunction with a trend towards a positive
influence on time for reperfusion (TRBCVmax), which
needs further elucidation. PORH is thought to be deter-
mined at the level of small arterioles [34] and to be
independent of the autonomic nervous system [35].
After the onset of reperfusion there is a sharp rise in
blood flow followed by a gradual return to its baseline
level, influenced by accumulation of vasodilator metabo-
lites (including nitric oxide) and formation of ROS, nor-
mally washed out or destroyed by circulating blood and
smooth muscle cell reactivity. During reperfusion, the
myogenic response, due to rapid stretch of microvascu-
lar smooth muscle cells, is responsible, at least partially,
for the return of blood flow to its baseline values. Our
sample size did not allow us to correlate variables to
find out associations between them, but we suppose that
higher intake of MUFAs and PUFAs by obese adoles-
cents on BNG resulting in an improved lipid profile and
lower levels of LDL-ox, positively influenced microvas-
cular reactivity. To strengthen this hypothesis we have
previously noticed a multiple association between total
and LDL-cholesterol levels and capillary microflow on
obese metabolic syndrome subjects [19], suggesting that
interventions with beneficial effects on the lipid profile
could positively influence RBCV and RBCVmax. Consump-
tion of nutrients rich in PUFAs (especially linolenic acids)
such as fish oil and also Brazil nuts was associated to
reduction in fibrinogen levels and in blood viscosity [36].
Nuts as sources of MUFAs have also been inserted in
diets aiming to improve not only lipid profile but also
insulin sensitivity, but in healthy, type 2 diabetes mellitus
patients [37], and our own results in obese adolescents,
nuts-enriched diets did not influence glucose homeostasis
and CRP, an acute-phase protein, associated to athero-
sclerosis, metabolic disorders and CV disease [38].
Brazil nuts consumption during 15 days increased
selenium levels, showing that shorter periods with
higher amounts of nuts per day were followed by incre-
ments of 370% on selenium levels [24]. Physiological
values for selenium ranged from 53 to 161.1 μg/l [39].
In the present study, selenium levels increased on BNG
and were considered as a marker of good compliance
although a significant difference could not be found
inter-group (perhaps the intervention time was too
short). Oxidative imbalance has been pointed as a causal
factor for CVD. Nutrients and bioactive substances with
antioxidant action are able to avoid arachidonic acid
oxidation [33] and improvement of lipid peroxidation
could reduce plasmatic and urinary levels of 8-epi-PGF2a,
an oxidative product of arachidonic acid related to cell
membranes. Urinary 8-epi-PGF2a levels, also called iso-
prostanes, have shown large variation already at baseline
inter- (two adolescents at PG had reduced urinary 8-epi-
PGF2a levels) and also intra-group in a reduced sample
size and no significant changes could be detected on
either group. However, we have noticed that its levels in
BNG showed a decremental direction while in PG results
went in the opposite way. It should be recalled that iso-
prostanes, derived from the arachidonic acid, are only
Figure 2 Resting Red Blood Cell Velocity (RBCV) and RBCVmax during post-occlusive reactive hyperemia response (PORH) on obese
female adolescents at baseline and after 16 weeks of Brazil nuts (BNG) or placebo (PG) intake. *p = 0.03 (intra-group) and †p = 0.03
(inter-group).
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not able to reflect the whole oxidative status on cell
membranes. Although our data do not explain improve-
ments in the nutritive microvascular reactivity by an
amelioration of urinary isoprostanes, we suggest that this
pathophysiological focus deserves further elucidation
with the use of other biomarkers of oxidative stress.
While investigated markers of oxidative stress were
not altered by Brazil nuts consumption (Table 2), we
could notice that LDL-ox levels were significantly
reduced in BNG, probably due to reduction on oxidative
stress status. The exact mechanism involved on it was
not our aim, but the knowledge that LDL-ox is asso-
ciated to endothelial dysfunction and atherosclerosis rise
possible questions about the beneficial long-term effects
of Brazil nuts consumption on obesity.
Limitations of the present study warrant mention.
Although a power analysis was done to strengthen our
results, the reduced number of patients investigated limits
our conclusion to the population studied. Although the
present study was randomized, it was not blinded and we
have to consider that some changes in diet that we were
not aware of, might have happened. Long-term beneficial
cardiovascular outcomes could be inferred by these data.
Finally, treatment strategies for obese adolescent
should focus on lifestyle interventions, aiming weight
reduction, even if some supplements with established
beneficial effects are added to diets.
Conclusion
Our results show that short-term intake of Brazil nuts
added to diet of an obese female adolescent group did
not change body mass or waist circumference, but, as a
nutrient rich in bioactive substances, it positively influ-
enced lipid profile and nutritive microvascular reactivity.
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